| Serial Number | 79431868 |
| Word Mark | SEQITOPE |
| Filing Date | Friday, July 11, 2025 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Monday, March 30, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Scientific research, development, engineering, laboratory, and testing services in the field of biochemistry and biotechnology; research, development, engineering, testing, consulting, and analytical services for analysing and quantifying the diversity of the immune system and immune system therapeutics; research, development, engineering, testing, consulting, and analytical services for discovering immune targets in the field of medical research; research, engineering, testing, consulting, and analytical services for epitope mapping; providing sequencing data and analysis of the immune system for vaccine development and vaccine optimisation; research and development of antibodies, therapeutics, vaccines, immunotherapies, and diagnostics; research services in the field of immune repertoire analysis, personalised medicine, vaccines, immunotherapies, and diagnostics being diagnostic preparations and related consultation services; providing computational analysis of the immune repertoire; research, development, engineering, testing, consulting, laboratory, and analytical services in the field of drug discovery and drug screening; scientific and technological services, namely, scientific research, analysis and testing in the field of biochemistry and biotechnology and research and design relating thereto; industrial analysis and research services in the field of biochemistry and biotechnology; design and development of computer hardware and software. |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 4, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | AAX Biotech AB |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | SE |
| Event Date | Event Description |
| Thursday, September 4, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, September 8, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 8, 2025 | APPLICATION FILING RECEIPT MAILED |
| Monday, December 1, 2025 | ASSIGNED TO EXAMINER |
| Monday, December 1, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, December 2, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, January 8, 2026 | REFUSAL PROCESSED BY MPU |
| Thursday, January 8, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, January 22, 2026 | REFUSAL PROCESSED BY IB |
| Friday, March 27, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 27, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 27, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 30, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |